Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
2 "Immunohistochemistry"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Inflammatory bowel diseases
Pathophysiological role of Atg5 in human ulcerative colitis
Razieh Ardali, Nasrin Kazemipour, Saeed Nazifi, Kamran Bagheri Lankarani, Iman Razeghian Jahromi, Masood Sepehrimanesh
Intest Res 2020;18(4):421-429.   Published online May 8, 2020
DOI: https://doi.org/10.5217/ir.2019.00120
AbstractAbstract PDFPubReaderePub
Background/Aims
Ulcerative colitis (UC), along with Crohn’s disease, is one of the main types of inflammatory bowel disease (IBD). On the other hand, deregulated autophagy is involved in many chronic diseases, including IBD. In this study, we aimed to investigate the role of Atg5 and microRNA-181a (miR-181a) in the pathophysiology of UC.
Methods
Colon biopsy, stool, and blood samples of 6 men and 9 women were confirmed for UC. Also, 13 men and 17 women were selected as healthy control (HC). Enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry were used to measure the Atg-5 content of the colon biopsies. Besides, the serum and stool levels of Atg5 were measured using ELISA. Moreover, the total RNA of blood cells was extracted and evaluated for the expression of miR-181a.
Results
We found 1.2 ng/mL versus 0.46 ng/mL, 0.34 ng/mL versus 0.24 ng/mL, and 0.082 ng/mL versus 0.062 ng/mL of Atg5 in stool, intestinal tissue, and serum of UC and HCs, respectively. There was no significant difference in the expression of miR-181a in the blood samples of UC and HCs. Immunohistochemistry showed high positivity without any significant difference between the 2 groups in the quantitative analysis.
Conclusions
The significant difference observed between the stool Atg5 content of the HCs and UC patients may provide new insight into using this protein as a diagnostic biomarker, however, considering the small size of our studied population further studies are needed.

Citations

Citations to this article as recorded by  
  • Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date
    Alessandro Giammona, Bruno Giovanni Galuzzi, Elena Imperia, Clarissa Gervasoni, Sofia Remedia, Laura Restaneo, Martina Nespoli, Laura De Gara, Flaminia Tani, Michele Cicala, Michele Pier Luca Guarino, Danilo Porro, Antonio Cerasa, Alessia Lo Dico, Annamar
    International Journal of Molecular Sciences.2025; 26(1): 413.     CrossRef
  • Circular RNAs in inflammatory bowel disease: a review of mechanisms, biomarkers and therapeutic potential
    Le Yang, Huahui Li, Min Tang, Lingnan He, Lijun Yang
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits
    Jiao Zhou, Chunxia Li, Meng Lu, Gaoyue Jiang, Shanze Chen, Huihui Li, Kefeng Lu, Hans-Uwe Simon
    PLOS Biology.2024; 22(3): e3002537.     CrossRef
  • Autophagy: A potential target for natural products in the treatment of ulcerative colitis
    Wei Zhang, Menglong Zou, Jia Fu, Yin Xu, Ying Zhu
    Biomedicine & Pharmacotherapy.2024; 176: 116891.     CrossRef
  • Deficiency of Autophagy-Related Gene 5 in Keratinocytes Leads to Aggravation of Epidermal Damage in 2,4-Dinitrochlorobenzene-Induced Allergic Contact Dermatitis
    Yi-Qun Zhang, Ta Xiao, Chang-Jun Song, Yang-Ying Ke, Xiang Gao, Min Li, Heng Gu, Xu Chen
    International Journal of Dermatology and Venereology.2023; 6(4): 214.     CrossRef
  • Circular RNA HECTD1 Mitigates Ulcerative Colitis by Promoting Enterocyte Autophagy Via miR-182-5p/HuR Axis
    Yan Xu, Yuxi Tian, Fujun Li, Ying Wang, Junwen Yang, Hui Gong, Xiaoping Wan, Miao Ouyang
    Inflammatory Bowel Diseases.2022; 28(2): 273.     CrossRef
  • Personalized medicine in inflammatory bowel disease: Perspectives on Asia
    Su Hyun Park, Sang Hyoung Park
    Journal of Gastroenterology and Hepatology.2022; 37(8): 1434.     CrossRef
  • Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
    Soo-Young Na, You Sun Kim
    The Korean Journal of Internal Medicine.2022; 37(5): 906.     CrossRef
  • A study on the potential role of autophagy‐related protein 10 as a biomarker for ulcerative colitis
    Fatemeh Abbasi Teshnizi, Nasrin Kazemipour, Saeed Nazifi, Kamran Bagheri Lankarani, Masood Sepehrimanesh, Iman Razeghian Jahromi
    Physiological Reports.2021;[Epub]     CrossRef
  • Regulation of Endoplasmic Reticulum Stress-Autophagy: A Potential Therapeutic Target for Ulcerative Colitis
    Dan Qiao, Ziwei Zhang, Yali Zhang, Qian Chen, Yujun Chen, Yingjue Tang, Xiong Sun, Zhipeng Tang, Yancheng Dai
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • 7,757 View
  • 139 Download
  • 9 Web of Science
  • 10 Crossref
Close layer
IBD
Immunohistochemical differentiation between chronic enteropathy associated with SLCO2A1 gene and other inflammatory bowel diseases
Satoko Yamaguchi, Shunichi Yanai, Shotaro Nakamura, Keisuke Kawasaki, Makoto Eizuka, Noriyuki Uesugi, Tamotsu Sugai, Junji Umeno, Motohiro Esaki, Takayuki Matsumoto
Intest Res 2018;16(3):393-399.   Published online July 27, 2018
DOI: https://doi.org/10.5217/ir.2018.16.3.393
AbstractAbstract PDFPubReaderePub
<b>Background/Aims</b><br/>

We recently identified recessive mutations in the solute carrier organic anion transporter family member 2A1 gene (SLCO2A1) as causative variants of chronic enteropathy associated with SLCO2A1 (CEAS). The aim of this study was to evaluate SLCO2A1 protein expression in the intestinal tissues of patients with CEAS, intestinal Behçet's disease (BD), simple ulcer (SU), and Crohn's disease (CD).

Methods

Immunohistochemical staining using a polyclonal anti-SLCO2A1 antibody was performed on the resected intestinal specimens from 13 cases of CD, 9 cases of intestinal BD/SU, and 3 cases of CEAS. The extent of SLCO2A1 expression was determined by counting positively-staining vascular endothelial cells and scored as 0 (no cells), 1 (1%–30% cells), 2 (31%–60%), or 3 (>60%). The intensity of SLCO2A1 expression was scored either as 0 (negative), 1 (intermediate), or 2 (strong). The extent score and intensity score were summed for the final score of 0, 2, 3, 4, or 5.

Results

SLCO2A1 protein expression was observed in 1 of 3 cases of CEAS (33%), all 13 cases of CD (100%), and all 9 cases of BD/SU (100%). The mean final expression scores of CEAS, CD, and BD/SU were 1.6 (range, 0–5), 4.8 (range, 4–5), and 4.3 (range, 4–5), respectively. The final expression score in CEAS was significantly lower than in CD (P=0.03).

Conclusions

Immunohistochemical staining of the SLCO2A1 protein is considered useful to distinguish CEAS from other inflammatory bowel diseases.

Citations

Citations to this article as recorded by  
  • Chronic Enteropathy Associated with SLCO2A1 Gene
    Junji Umeno, Motohiro Esaki, Keiichi Uchida, Takayuki Matsumoto
    Inflammatory Intestinal Diseases.2025; 10(1): 193.     CrossRef
  • First case report of dichorionic diamniotic twins with chronic enteropathy associated with the SLCO2A1 gene
    Ryutaro Saura, Shin-ichiro Hagiwara, Keinosuke Hizuka, Nobuhiko Okamoto, Yuri Etani
    Clinical Journal of Gastroenterology.2024; 17(2): 240.     CrossRef
  • Characteristics of chronic enteropathy associated with SLCO2A1 gene (CEAS) in children, a unique type of monogenic very early-onset inflammatory bowel disease
    Jin Gyu Lim, Jae Sung Ko, Jung Min Ko, Hyun Young Kim, Man Jin Kim, Moon Woo Seong, Young Hun Choi, Gyeong Hoon Kang, Jaemoon Koh, Jin Soo Moon
    BMC Pediatrics.2024;[Epub]     CrossRef
  • Clinical and genetic characteristics of Chinese patients diagnosed with chronic enteropathy associated with SLCO2A1 gene
    Qing Shang, Yimin Dai, Jingyi Huang, Wei Liu, Weixun Zhou, Yaping Liu, Hong Yang, Qiang Wang, Yue Li
    Orphanet Journal of Rare Diseases.2024;[Epub]     CrossRef
  • Histopathology underlying environmental enteric dysfunction in a cohort study of undernourished children in Bangladesh, Pakistan, and Zambia compared with United States children
    Paul Kelly, Kelley VanBuskirk, David Coomes, Samer Mouksassi, Gerald Smith, Zehra Jamil, Md Shabab Hossain, Sana Syed, Chelsea Marie, Phillip I Tarr, Peter B Sullivan, William A Petri, Donna M Denno, Tahmeed Ahmed, Mustafa Mahfuz, S Asad Ali, Sean R Moore
    The American Journal of Clinical Nutrition.2024; 120: S15.     CrossRef
  • Capsule Endoscopy for the Diagnosis of Suspected Small Bowel Bleeding
    P. P. Polyakov, A. Ya. Alimetov, A. V. Onopriev, A. V. Avakimyan, A. Kh. Kade, S. A. Zanin, E. S. Zanina, Z. S. Popov, A. I. Trofimenko, Z. T. Jndoyan, A. A. Avagimyan
    Innovative Medicine of Kuban.2023; (3): 121.     CrossRef
  • Attenuated Expression of SLCO2A1 Caused by DNA Methylation in Pediatric Inflammatory Bowel Disease
    Natsuki Ito, Takahiro Kudo, Hidetaka Eguchi, Keisuke Jimbo, Atsushi Furuhata, Toshiaki Okuno, Ichiro Takeuchi, Katsuhiro Arai, Takashi Ishige, Yasushi Okazaki, Toshiaki Shimizu
    Inflammatory Bowel Diseases.2023; 29(12): 1920.     CrossRef
  • Updates on the diagnosis and management of cryptogenic multifocal ulcerative stenosing enteropathy (CMUSE) and non-steroidal enteropathy
    Tom G. Moreels, Ayaskanta Singh
    Best Practice & Research Clinical Gastroenterology.2023; 64-65: 101847.     CrossRef
  • Chronic Enteropathy Associated with Solute Carrier Organic Anion Transporter Family, Member 2A1 (SLCO2A1) with Positive Immunohistochemistry for SLCO2A1 Protein
    Chizuru Ariake, Naoki Hosoe, Hinako Sakurai, Anna Tojo, Yukie Hayashi, Kenji JL Limpias Kamiya, Tomohisa Sujino, Kaoru Takabayashi, Kenjiro Kosaki, Satowa Seki, Tadakazu Hisamatsu, Haruhiko Ogata, Takanori Kanai
    Internal Medicine.2022; 61(17): 2607.     CrossRef
  • Epithelial Abnormalities in the Small Intestine of Zambian Children With Stunting
    Chola Mulenga, Sanja Sviben, Kanta Chandwe, Beatrice Amadi, Violet Kayamba, James A. J. Fitzpatrick, Victor Mudenda, Paul Kelly
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Functional analysis of mutant SLCO2A1 transporters found in patients with chronic enteropathy associated with SLCO2A1
    Satowa Seki, Gen Tanaka, Toru Kimura, Mari Hayashida, Jun Miyoshi, Minoru Matsuura, Hiroyuki Sakurai, Tadakazu Hisamatsu
    Journal of Gastroenterology and Hepatology.2022; 37(9): 1776.     CrossRef
  • Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study
    Hee Seung Hong, Jiwon Baek, Jae Chul Park, Ho-Su Lee, Dohoon Park, A-Ran Yoon, Soo Jung Park, Sung Noh Hong, Seong-Joon Koh, Chang Kyun Lee, Bo-In Lee, Sung Wook Hwang, Sang Hyoung Park, Seung-Jae Myung, Suk-Kyun Yang, Kyuyoung Song, Byong Duk Ye
    Gut and Liver.2022; 16(6): 942.     CrossRef
  • Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action
    Takeo Nakanishi, Yoshinobu Nakamura, Junji Umeno
    Pharmacology & Therapeutics.2021; 223: 107803.     CrossRef
  • Meta-Analysis-Assisted Detection of Gravity-Sensitive Genes in Human Vascular Endothelial Cells
    Yin Liang, Mengxue Wang, Yun Liu, Chen Wang, Ken Takahashi, Keiji Naruse
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Chronic Nonspecific Multiple Ulcers of the Small Intestine / Chronic Enteropathy Associated with SLCO2A1 Gene (CEAS)
    Junji Umeno, Yuta Fuyuno, Yuichi Matsuno, Takehiro Torisu
    Nippon Daicho Komonbyo Gakkai Zasshi.2021; 74(10): 581.     CrossRef
  • Retrospective study of the differential diagnosis between cryptogenic multifocal ulcerous stenosing enteritis and small bowel Crohn’s disease
    Dan Chen, Wei Liu, Weixun Zhou, Weiyang Zheng, Dong Wu, Jiaming Qian
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Chronic Enteropathy Associated with SLCO2A1 with Pachydermoperiostosis
    Yoshikazu Tsuzuki, Ryutaro Aoyagi, Kazuya Miyaguchi, Keigo Ashitani, Hideki Ohgo, Minoru Yamaoka, Keisuke Ishizawa, Hidekazu Kayano, Tadakazu Hisamatsu, Junji Umeno, Naoki Hosoe, Takayuki Matsumoto, Hidetomo Nakamoto, Hiroyuki Imaeda
    Internal Medicine.2020; 59(24): 3147.     CrossRef
  • Small bowel ulcers
    Martin Keuchel, Niehls Kurniawan, Peter Baltes
    Current Opinion in Gastroenterology.2019; 35(3): 213.     CrossRef
  • Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations
    Yuichi Matsuno, Junji Umeno, Motohiro Esaki, Yoichiro Hirakawa, Yuta Fuyuno, Yasuharu Okamoto, Atsushi Hirano, Shigeyoshi Yasukawa, Fumihito Hirai, Toshiyuki Matsui, Shuhei Hosomi, Kenji Watanabe, Naoki Hosoe, Haruhiko Ogata, Tadakazu Hisamatsu, Shunichi
    World Journal of Gastroenterology.2019; 25(14): 1753.     CrossRef
  • Distinction between Chronic Enteropathy Associated with the SLCO2A1 Gene and Crohn's Disease
    Shunichi Yanai, Satoko Yamaguchi, Shotaro Nakamura, Keisuke Kawasaki, Yosuke Toya, Noriyuki Yamada, Makoto Eizuka, Noriyuki Uesugi, Junji Umeno, Motohiro Esaki, Eiko Okimoto, Shunji Ishihara, Tamotsu Sugai, Takayuki Matsumoto
    Gut and Liver.2019; 13(1): 62.     CrossRef
  • Chronic enteropathy associated with SLCO2A1 gene: A case report and literature review
    Peng Hu, Huiqin He, Ning Dai, Shizheng Zhang, Liping Deng
    Clinics and Research in Hepatology and Gastroenterology.2019; 43(5): e68.     CrossRef
  • 9,679 View
  • 122 Download
  • 18 Web of Science
  • 21 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP